Rakuten Securities’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$47.5K Sell
250
-100
-29% -$17.2K 0.01% 272
2026
Q1
$59.1K Buy
350
+254
+265% +$43.4K 0.02% 219
2025
Q4
$16.2K Buy
96
+93
+3,100% +$15.1K 0.01% 360
2025
Q3
$433 Sell
3
-18
-86% -$2.46K ﹤0.01% 778
2025
Q2
$2.66K Sell
21
-14
-40% -$1.72K ﹤0.01% 573
2025
Q1
$4.48K Buy
35
+33
+1,650% +$4.47K ﹤0.01% 504
2024
Q4
$264 Sell
2
-74
-97% -$10.4K ﹤0.01% 694
2024
Q3
$11.1K Buy
76
+61
+407% +$8.83K ﹤0.01% 331
2024
Q2
$2.06K Sell
15
-58
-79% -$7.74K ﹤0.01% 487
2024
Q1
$10K Buy
+73
New +$9.97K ﹤0.01% 328

Other funds holding IBB

Rakuten Securities's IBB Position: Q2 2026 in Review

Rakuten Securities reduced its iShares Biotechnology ETF (IBB) stake by 29% in Q2 2026, selling an estimated $17.2K and leaving 250 shares worth $47.5K. The position accounts for 0.01% of the portfolio, ranked #272.

Rakuten Securities first reported a position in IBB in Q1 2024 and has held it in 10 quarters since. The position peaked at $59.1K in Q1 2026. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Rakuten Securities held 250 shares of iShares Biotechnology ETF worth $47.5K as of Q2 2026.
  • Rakuten Securities sold 100 iShares Biotechnology ETF shares in Q2 2026, an estimated $17.2K.
  • iShares Biotechnology ETF made up 0.01% of Rakuten Securities's portfolio in Q2 2026, its #272 holding.
  • Rakuten Securities first reported a position in iShares Biotechnology ETF in Q1 2024 and has held it in 10 quarters since.
  • Rakuten Securities's iShares Biotechnology ETF position peaked at $59.1K in Q1 2026.
  • 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Rakuten Securities's 13F filing for Q2 2026, filed 12 Aug 2026.